Newsmeme!
Discover News you didn't know existed
Washington, Oct 10 : A new study at Johns Hopkins Children's Center has raised questions against the age-old practice of treating premature babies with hydrocortisone, a steroid considered to fight inflammation and prevent lung disease.
Results of a multicenter study led by Johns Hopkins Children's Center challenge the longstanding practice of treating premature babies with hydrocortisone, a steroid believed to fight inflammation and prevent lung disease. The researchers found that such treatment offers little or no benefit and that low cortisol levels are not even necessarily harmful.
Washington, Oct 10 : The practice of treating premature babies with hydrocortisone, a steroid believed to fight inflammation and prevent lung disease, offers little or no benefit, according to the latest research.
Results of a multicenter study led by Johns Hopkins Children's Center challenge the longstanding practice of treating premature babies with hydrocortisone, a steroid believed to fight inflammation and prevent lung disease. The researchers found that such treatment offers little or no benefit and that low cortisol levels are not even necessarily harmful. High cortisol levels, on the other hand, ...
Results of a multicenter study led by Johns Hopkins Children's Center challenge the longstanding practice of treating premature babies with hydrocortisone, a steroid believed to fight inflammation and prevent lung disease.
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that 1.5 g mesalamine granules once-daily maintained remission versus placebo in ulcerative colitis (UC) patients who switched from another 5-ASA product (78 percent of relapse-free subjects vs. 59 percent [P
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the successful completion and outcome of its pivotal Phase 3 trial to evaluate the efficacy, safety and tolerability of rifaximin in preventing hepatic encephalopathy, or HE.
ORLANDO, Fla.----Salix Pharmaceuticals, Ltd. today announced that 1.5 g mesalamine granules once-daily maintained remission versus placebo in ulcerative colitis patients who switched from another 5-ASA product .
Salix Pharmaceuticals, Ltd. today announced that 1.5 g mesalamine granules once-daily maintained remission versus placebo in ulcerative colitis patients who switched from another 5-ASA product. These patients also had a greater probability of remaining relapse free after six months compared to placebo. Mesalamine granules are being studied as a 5-ASA with both a delayed and extended release ...
Q: I am seeing a new guy, and the stubble on his face has left a large chapped area on my face that almost feels burned. It's an unpleasant aftermath of an enjoyable kissing session. I'm putting Vaseline on it. Is there anything else that might help more?
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |